Onco-Innovations closes $1.21M private placement

Executive Summary

• Onco-Innovations Ltd. has closed its previously announced non-brokered private placement, raising aggregate gross proceeds of $1,215,500.
• The company issued 1.87 million units at a price of 65 cents per unit, with each unit consisting of one common share and one common share purchase warrant.
• Proceeds are designated for general corporate and working capital purposes, including operational, R&D, and investor relations objectives.

Key Details

• Units Issued: 1.87 million units.
• Price Per Unit: 65 cents.
• Gross Proceeds: $1,215,500.
• Warrant Terms: Each unit includes one common share purchase warrant. Each warrant entitles the holder to purchase one additional share at an exercise price of 75 cents.
• Warrant Expiration: March 12, 2029 (three-year term from closing).
• Use of Proceeds: General corporate and working capital purposes, specifically for operational, research and development, and investor relations objectives.
• Administrative Services: The company issued 18,700 shares to an arm's-length third party as consideration for administrative services rendered in connection with the private placement.
• Statutory Hold: All securities are subject to a statutory hold period of four months and one day.
• Previous Announcements: This closing relates to announcements dated January 23, 2026, and an amendment dated February 12, 2026.